Cost of diabetes-related complications: current issues, future directions

Authors: Summers, Kent; Songer, Thomas J

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 3, Number 1, February 2003 , pp. 17-24(8)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

The costs of diabetes are significant, approaching US$100 billion. Medical costs for patients with diabetes are between two- and four-times higher per patient per year when compared to persons without diabetes. Long-term complications of diabetes are likely to account for much of this excess. However, the total economic burden related to diabetes complications is not fully understood due to several factors. These include diagnostic, comorbidity and coding issues, as well as limitations in longitudinal data and the lack of information on the impact to work productivity. Future diabetes care and cost estimates will benefit from the use of electronic medical records.

Keywords: burden; complications; cost; diabetes; economics; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737167.3.1.17

Publication date: 2003-02-01

More about this publication?

Expert Review of Pharmacoeconomics & Outcomes Research provides expert commentary on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites